Dexcom
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of DXCM would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2005) — listing | $456,856 14.3× | $663,340 14.3× |
| Year 6 (2010) | $177,884 7.2× | $258,991 7.2× |
| Year 11 (2015) | $34,088 2.0× | $49,479 2.0× |
| Year 16 (2020) | $7,706 0.8× | $11,197 0.8× |
| Year 21 (2025) | $2,110 1.0× | $3,072 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
San Diego, California, United States
Popular scenarios with DXCM
For illustration only — not investment advice. Past performance is not indicative of future results.